Literature DB >> 6418147

The uptake of ornithine and lysine by rat liver mitochondria.

F A Hommes, L Kitchings, A G Eller.   

Abstract

Ornithine and lysine are taken up by rat liver mitochondria with an apparent Km of 1.3 and 2.4 mM, respectively. Neither lysine methylester alpha-N-acetyl lysine, nor epsilon-N-acetyl lysine inhibits the uptake of either ornithine or lysine. The zwitterionic form of these amino acids is taken up by liver mitochondria. Lysine inhibits the uptake of ornithine and vice versa. The inhibition is in both cases of the mixed type. Arginine strongly inhibits the uptake of both ornithine and lysine. Alkalinization of the mitochondrial matrix decreases the rate of uptake of ornithine and of lysine, while acidification of the mitochondrial matrix increases these rates. It is concluded that ornithine and lysine are taken up via a common carrier in exchange for H+.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418147     DOI: 10.1016/0006-2944(83)90022-4

Source DB:  PubMed          Journal:  Biochem Med        ISSN: 0006-2944


  7 in total

1.  The purified and reconstituted ornithine/citrulline carrier from rat liver mitochondria: electrical nature and coupling of the exchange reaction with H+ translocation.

Authors:  C Indiveri; A Tonazzi; I Stipani; F Palmieri
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

2.  The purified and reconstituted ornithine/citrulline carrier from rat liver mitochondria catalyses a second transport mode: ornithine+/H+ exchange.

Authors:  C Indiveri; A Tonazzi; I Stipani; F Palmieri
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

Review 3.  Yeast mitochondrial carriers: bacterial expression, biochemical identification and metabolic significance.

Authors:  L Palmieri; M J Runswick; G Fiermonte; J E Walker; F Palmieri
Journal:  J Bioenerg Biomembr       Date:  2000-02       Impact factor: 2.945

4.  Inhibitory effect of intravenous lysine infusion on urea cycle metabolism.

Authors:  T Kato; M Sano; N Mizutani
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

5.  The pH of mitochondria of fibroblasts from a hyperornithinaemia, hyperammonaemia, homocitrullinuria-syndrome patient.

Authors:  K Metoki; F A Hommes
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

6.  Increased urinary excretion of putrescine in hyperargininaemia.

Authors:  T Kato; M Sano; N Mizutani; C Hayakawa
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 7.  Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy.

Authors:  Gerald Kircheis; Stefan Lüth
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.